Vertex Pharmaceuticals (VRTX)
NASDAQ: VRTX
· Real-Time Price · USD
396.12
-0.81 (-0.20%)
At close: Sep 05, 2025, 3:59 PM
396.00
-0.03%
After-hours: Sep 05, 2025, 07:31 PM EDT
Vertex Pharmaceuticals Revenue
Vertex Pharmaceuticals reported an annual revenue of $11.02B, reflecting a 11.66% growth. For the quarter ending June 30, 2025, Vertex Pharmaceuticals generated $2.96B in revenue.
Revenue (ttm)
11.02B
Revenue Growth
11.66%
Price / Sales Ratio
9.41
Revenue / Employee
1.81M
Employees
6,100
Market Cap
101.56B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 11.02B | +11.66% |
| Dec 31, 2023 | 9.87B | +10.51% |
| Dec 31, 2022 | 8.93B | +17.91% |
| Dec 31, 2021 | 7.57B | +22.06% |
| Dec 31, 2020 | 6.21B | +49.07% |
| Dec 31, 2019 | 4.16B | +36.59% |
| Dec 31, 2018 | 3.05B | +22.46% |
| Dec 31, 2017 | 2.49B | +46.20% |
| Dec 31, 2016 | 1.7B | +64.89% |
| Dec 31, 2015 | 1.03B | +77.86% |
| Dec 31, 2014 | 580.41M | -52.11% |
| Dec 31, 2013 | 1.21B | -20.63% |
| Dec 31, 2012 | 1.53B | +8.25% |
| Dec 31, 2011 | 1.41B | +883.91% |
| Dec 31, 2010 | 143.37M | +40.49% |
| Dec 31, 2009 | 102.05M | -41.85% |
| Dec 31, 2008 | 175.5M | -11.81% |
| Dec 31, 2007 | 199.01M | -8.02% |
| Dec 31, 2006 | 216.36M | +34.47% |
| Dec 31, 2005 | 160.89M | +56.63% |
| Dec 31, 2004 | 102.72M | +48.56% |
| Dec 31, 2003 | 69.14M | -57.08% |
| Dec 31, 2002 | 161.09M | -3.82% |
| Dec 31, 2001 | 167.49M | +114.38% |
| Dec 31, 2000 | 78.13M | +26.83% |
| Dec 31, 1999 | 61.6M | +38.74% |
| Dec 31, 1998 | 44.4M | +1.37% |
| Dec 31, 1997 | 43.8M | +229.32% |
| Dec 31, 1996 | 13.3M | -39.82% |
| Dec 31, 1995 | 22.1M | +12.76% |
| Dec 31, 1994 | 19.6M | -29.75% |
| Dec 31, 1993 | 27.9M | +634.21% |
| Dec 31, 1992 | 3.8M | +18.75% |
| Dec 31, 1991 | 3.2M | +39.13% |
| Dec 31, 1990 | 2.3M | n/a |